Abstract Details

Title Alemtuzumab Improves Patient-reported Quality of Life Outcomes in Patients With Rapidly Evolving Severe Relapsing-remitting MS: Results From the CARE-MS I Extension Study

Topic Multiple Sclerosis

Presentation(s) P6 - (-)

Poster/Presentation
Number 392

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Rafael Arroyo Gonzalez PRESENTER	Rafael Arroyo Gonzalez has nothing to disclose.
Jennifer Guo (Sanofi)	No disclosure on file
	No disclosure on file
	No disclosure on file
Luke Chung (Sanofi Genzyme)	Luke Chung has received personal compensation for serving as an employee of Sanofi Genzyme. Luke Chung has received stock or an ownership interest from Sanofi Genzyme.
	No disclosure on file
	No disclosure on file
David Cella, PhD (Northwestern Feinberg School of Medicine)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��